Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Handrean Soran

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Current Opinion in Lipidology|June 18, 2024
Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosisPaul Durrington, Handrean Soran
Diabetes, Obesity & Metabolism|December 22, 2005
Insulin detemir: a new basal insulin analogueHandrean Soran, Naveed Younis
Expert Opinion on Pharmacotherapy|August 2, 2008
Rosuvastatin: efficacy, safety and clinical effectivenessHandrean Soran, Paul Durrington
Current Opinion in Lipidology|July 8, 2011
Susceptibility of LDL and its subfractions to glycationHandrean Soran, Paul N Durrington
Circulation|February 15, 2017
Cholesterol Levels Should Play a More Important Role in Identifying Statin RecipientsPaul N Durrington, Handrean Soran
Atherosclerosis|April 3, 2021
Cholesterol lowering in secondary prevention: Could do betterPaul N Durrington, Handrean Soran
BMJ (Clinical Research Ed.)|April 26, 2013
Don't miss familial hypercholesterolaemia in Achilles tendinopathyJonathan Schofield, Michael France, Handrean Soran
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 27, 2017
Evidence-based goals in LDL-C reductionHandrean Soran, Ricardo Dent, Paul Durrington
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 21, 2019
Cardiovascular Risk in Type 1 Diabetes MellitusJonathan Schofield, Jan Ho, Handrean Soran
Expert Opinion on Pharmacotherapy|October 31, 2009
Vildagliptin in clinical practice: a review of literatureMoulinath Banerjee, Naveed Younis, Handrean Soran
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Current Opinion in Lipidology|June 18, 2024
Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosisPaul Durrington, Handrean Soran
Diabetes, Obesity & Metabolism|December 22, 2005
Insulin detemir: a new basal insulin analogueHandrean Soran, Naveed Younis
Expert Opinion on Pharmacotherapy|August 2, 2008
Rosuvastatin: efficacy, safety and clinical effectivenessHandrean Soran, Paul Durrington
Current Opinion in Lipidology|July 8, 2011
Susceptibility of LDL and its subfractions to glycationHandrean Soran, Paul N Durrington
Circulation|February 15, 2017
Cholesterol Levels Should Play a More Important Role in Identifying Statin RecipientsPaul N Durrington, Handrean Soran
Atherosclerosis|April 3, 2021
Cholesterol lowering in secondary prevention: Could do betterPaul N Durrington, Handrean Soran
BMJ (Clinical Research Ed.)|April 26, 2013
Don't miss familial hypercholesterolaemia in Achilles tendinopathyJonathan Schofield, Michael France, Handrean Soran
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 27, 2017
Evidence-based goals in LDL-C reductionHandrean Soran, Ricardo Dent, Paul Durrington
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 21, 2019
Cardiovascular Risk in Type 1 Diabetes MellitusJonathan Schofield, Jan Ho, Handrean Soran
Expert Opinion on Pharmacotherapy|October 31, 2009
Vildagliptin in clinical practice: a review of literatureMoulinath Banerjee, Naveed Younis, Handrean Soran
Pageof 20